Bionomics

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

Elder's Force Index

Score

0.2

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 33 11.5 0.55% 0.86% 5.7% -6.1% -24.8%
SHORT 33 12.5 0.64% 1.50% 6.0% -6.1% 40.0%

Summary

Technical Analysis

Bionomics (BNO.AX)


Indicator:

ELDERS FORCE INDEX


Last Signal:

NEUTRAL


Trading: HOLD @ $0.135
Signal Strength: MEDIUM
Recommendation:

Volatility indicators highlight potential moves of a stock which can either move sharply in the updwards or downwards direction. This indicator allows stocks to be compared on a level playing field to highlight high and low volatility. Normally, falling markets are more likely to be volatile than a rising markets due to the emotion that gets tied to trading. Use volatility indicators in conjunction with other indicators to reduce exposure to false moves.


Bionomics (ASX:BNO)


Elders Force Index (EFI) measures the power behind a price movement using price and volume. The indicator can also be used to identify potential reversals and price corrections. The EFI is an oscillator that fluctuates between positive and negative values above and below a Zero Line.

Calculation: Elders Force Index (EFI):
1) Close – Close yesterday x Volume;


PROFILE: Bionomics (BNO.AX)


Stock Exchange: ASX
Company: Bionomics
Ticker Codes: | BNO.AX | ASX:BNO |

About Bionomics (ASX:BNO):

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancer in Australia, France, and the United States. It operates through Drug Discovery and Development, and Contract Services segments. The company's product pipeline includes BNC210, a novel and proprietary negative allosteric modulator, which is in Phase II clinical trial for the treatment of generalized anxiety disorder, as well as is in the initiation of a Phase II clinical trial in patients with post-traumatic stress disorder; BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that targets cancer stem cells; and BNC105, a vascular disrupting agent for the treatment of cancer, as well as disrupts the blood vessels that nourish tumors in cancer treatment. It also offers contract research services. The company has partnerships with Merck & Co., Inc.; Cancer Therapeutics Cooperative Research Centre; Genmab A/S; Laboratory Corporation of America (LabCorp); Athena Diagnostics; and Genetic Technologies Limited. Bionomics Limited was founded in 1998 and is based in Thebarton, Australia.

Top 10:

Elder's Force Index

Download
Company Close Change(%) Volume Value Signal
NHF NIB 6.82 15.8 4,054,736 -77,731 BEARISH
GNG GR Engineering Services 0.95 9.8 41,600 -119,409 BEARISH
WBC Westpac Banking Corporation 27.75 9.2 24,404,464 -3,675 BEARISH
OVH Onevue Holdings 0.49 8.9 426,122 -776 BEARISH
NAB National Australia Bank 25.81 7.9 23,451,421 -680 BEARISH
ANZ Australia & Banking 27.86 7.8 14,554,708 -15,214 BEARISH
AYS Amaysim Australia 0.76 7 283,622 -658 BEARISH
MEZ Meridian Energy 4.2 6.3 25,687 -1,415 BEARISH
ADH Adairs 1.75 5.7 1,892,559 -13,915 BEARISH
APE Ap Eagers Holdings 8.9 5.6 61,547 -325 BEARISH